Proanthocyanidin B2 alleviates cuprizone‐induced demyelination in mice by modulating the astrocytic xCT/GSH/GPX4 axis, reducing inflammation and oxidative stress, and protecting oligodendrocytes, offering a novel therapeutic strategy for multiple sclerosis. Here, SLC7A11 is linked to multiple sclerosis.